KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardelyx (ARDX) Liabilities and Shareholders Equity (2016 - 2025)

Ardelyx's Liabilities and Shareholders Equity history spans 13 years, with the latest figure at $501.6 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 15.11% year-over-year to $501.6 million; the TTM value through Dec 2025 reached $1.9 billion, up 25.19%, while the annual FY2025 figure was $501.6 million, 15.11% up from the prior year.
  • Liabilities and Shareholders Equity reached $501.6 million in Q4 2025 per ARDX's latest filing, up from $486.2 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $501.6 million in Q4 2025 to a low of $129.4 million in Q1 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $285.1 million, with a median of $253.2 million recorded in 2023.
  • Peak YoY movement for Liabilities and Shareholders Equity: tumbled 38.46% in 2022, then skyrocketed 100.02% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $149.9 million in 2021, then rose by 26.78% to $190.1 million in 2022, then surged by 56.57% to $297.6 million in 2023, then surged by 46.43% to $435.8 million in 2024, then grew by 15.11% to $501.6 million in 2025.
  • Per Business Quant, the three most recent readings for ARDX's Liabilities and Shareholders Equity are $501.6 million (Q4 2025), $486.2 million (Q3 2025), and $466.8 million (Q2 2025).